News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PEP news

Show

From To
Delivery of care
Mass rape and HIV in conflict-affected countries: despite relatively low incidence, researchers stress urgency of interventions for thousands of women in need

Mass rape during armed conflict may account for several thousand new cases of HIV per year in sub-Saharan Africa, according to an article in the journal AIDS. Researchers drew this

Published
30 September 2010
By
Kelly Safreed-Harmon
PEP
Truvada/Kaletra HIV PEP combination is safe and effective with a low rate of discontinuations

A post-exposure prophylaxis (PEP) combination of FTC/tenofovir (Truvada) with lopinavir/ritonavir (Kaletra) tablets is safe and generally well-tolerated, French investigators report in the online edition of the Journal

Published
09 September 2010
By
Michael Carter
PEP
Increasing demand for PEP in UK, but targets still missed

Surveys from regional hospitals presented to the second BHIVA/BASHH conference in Manchester showed that increasing numbers of patients are seeking post-exposure prophylaxis (PEP) following sexual

Published
27 April 2010
By
Gus Cairns
Epidemiology and behaviour
Number of UK gay men ever tested rises to two-thirds

By 2007, two-thirds of gay men in the UK had taken an HIV test at least once, a rise from below 50% in 2002. However

Published
17 September 2009
By
Roger Pebody
Transmission and prevention
Raltegravir may have role in PEP if exposure involves drug-resistant HIV

Raltegravir (Isentress) can be safely used as part of a post-exposure prophylaxis regimen and may be of particular value if the possible exposure involves highly

Published
20 November 2008
By
Michael Carter
Transmission and prevention
Unsuccessful post-exposure prophylaxis may still result in weaker HIV infection and lower viral load

HIV post-exposure prophylaxis, even when it fails to prevent infection, may still have benefits, a case report in the Journal of Acquired Immune Deficiency

Published
09 October 2008
By
Gus Cairns
PEP
IAS: Randomised comparison concludes d4T more tolerable than AZT in triple nuke PEP regimen

A small, randomised open-label trial comparing AZT (zidovudine, Retrovir) to d4T (stavudine, Zerit) in combination with 3TC (lamivudine, Epivir) and tenofovir (Viread) as part of

Published
23 July 2007
By
Edwin J. Bernard
PEP
Uneven PEP awareness amongst people living with HIV in France

A majority of HIV-positive immigrants in France are unaware of the availability of post-exposure prophylaxis (PEP), a study published in a supplement to the January

Published
29 December 2006
By
Michael Carter
PEP
CROI: Study reveals widespread misunderstandings about post-exposure prophylaxis among US doctors

The majority of calls to a helpline set up to advise doctors about non-occupational post-exposure prophylaxis (PEP)against HIV were made too late to offer much

Published
10 February 2006
By
Gus Cairns
PEP
Most people given non-occupational PEP fully adhere to their treatment

A total of 79% of individuals prescribed post-exposure prophylaxis (PEP) after a possible sexual exposure to HIV fully adhered to their 28 day course of

Published
19 January 2006
By
Michael Carter
← Prev12345Next →

Filter by country